Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25
Closed -$135 1040
2025
Q3
$135 Hold
25
﹤0.01% 942
2025
Q2
$136 Hold
25
﹤0.01% 915
2025
Q1
$70 Hold
25
﹤0.01% 903
2024
Q4
$86 Hold
25
﹤0.01% 866
2024
Q3
$74 Hold
25
﹤0.01% 853
2024
Q2
$85 Hold
25
﹤0.01% 802
2024
Q1
$76 Hold
25
﹤0.01% 786
2023
Q4
$106 Buy
+25
New +$136 ﹤0.01% 763

Other funds holding CVAC

DHJJ Financial Advisors's CVAC Position: Q4 2025 in Review

DHJJ Financial Advisors sold out of CureVac (CVAC) in Q4 2025, closing a stake of 25 shares — an estimated $135 sold.

DHJJ Financial Advisors first reported a position in CVAC in Q4 2023 and held it in 8 quarters. The position peaked at $136 in Q2 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • DHJJ Financial Advisors reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • DHJJ Financial Advisors sold 25 CureVac shares in Q4 2025, an estimated $135.
  • DHJJ Financial Advisors first reported a position in CureVac in Q4 2023 and held it in 8 quarters.
  • DHJJ Financial Advisors's CureVac position peaked at $136 in Q2 2025.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on DHJJ Financial Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.